Abstract
The proposed ban on some textured breast implants announced by the Australian pharmaceuticals and medical devices regulator earlier this week tells us something very disquieting about the effectiveness of consumer protection.
It will not reassure women living with breast implants concerned about their risk of cancer, or anyone else with an implantable medical device regulated by the Therapeutic Goods Administration (TGA).
It will not reassure women living with breast implants concerned about their risk of cancer, or anyone else with an implantable medical device regulated by the Therapeutic Goods Administration (TGA).
| Original language | English |
|---|---|
| Pages | 1-3 |
| Number of pages | 3 |
| Volume | 2019 |
| No. | July |
| Specialist publication | The Conversation |
| Publisher | The Conversation Paperpress |
| Publication status | Published - 12 Jul 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'The TGA’s proposed breast implant ban exposes a litany of failures, and fails to protect women'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver